These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 37746284

  • 1. Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro.
    Li S, Zhu Z, Lu J, Cao W, Song F, Xiao C, Zhang P, He Z, Weng J, Xu J.
    Front Oncol; 2023; 13():1159126. PubMed ID: 37746284
    [Abstract] [Full Text] [Related]

  • 2. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S, Bai H, Fei S, Miao B.
    Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914
    [Abstract] [Full Text] [Related]

  • 3. Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma.
    Zhu H, Mao F, Wang K, Feng J, Cheng S.
    Front Genet; 2022 Jun; 13():972212. PubMed ID: 36212138
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma.
    Liu B, Pang K, Feng C, Liu Z, Li C, Zhang H, Liu P, Li Z, He S, Tu C.
    Front Genet; 2022 Jun; 13():1063057. PubMed ID: 36568384
    [Abstract] [Full Text] [Related]

  • 5. A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma.
    Liu Y, Jiang J.
    Cancer Biomark; 2023 Jun; 37(1):13-26. PubMed ID: 37005878
    [Abstract] [Full Text] [Related]

  • 6. Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology.
    Ma C, Li F, He Z, Zhao S, Yang Y, Gu Z.
    Front Pharmacol; 2023 Jun; 14():1113808. PubMed ID: 36874011
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma.
    Liu C, Wu S, Lai L, Liu J, Guo Z, Ye Z, Chen X.
    BMC Bioinformatics; 2023 Jan 03; 24(1):4. PubMed ID: 36597032
    [Abstract] [Full Text] [Related]

  • 8. A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma.
    Wu J, Yao J, Jia S, Yao X, Shao J, Cao W, Ma S, Yao X, Li H.
    Heliyon; 2023 Sep 03; 9(9):e19352. PubMed ID: 37810122
    [Abstract] [Full Text] [Related]

  • 9. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
    Huang EM, Ma N, Ma T, Zhou JY, Yang WS, Liu CX, Hou ZH, Chen S, Zong Z, Zeng B, Li YR, Zhou TC.
    World J Gastrointest Oncol; 2022 Oct 15; 14(10):1981-2003. PubMed ID: 36310708
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma.
    Yu S, Tang L, Zhang Q, Li W, Yao S, Cai Y, Cheng H.
    Hereditas; 2023 Jul 24; 160(1):31. PubMed ID: 37482612
    [Abstract] [Full Text] [Related]

  • 12. Identification of a cuproptosis and copper metabolism gene-related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma.
    Yuan W, Xiao JH, Zhang JS, Mao BL, Wang PZ, Wang BL.
    Front Oncol; 2023 Jul 24; 13():1153353. PubMed ID: 37056336
    [Abstract] [Full Text] [Related]

  • 13. Analysis of m6A-related lncRNAs for prognostic and immunotherapeutic response in hepatocellular carcinoma.
    Wu X, Wang S, Wu X, Chen Q, Cheng J, Qi Z.
    J Cancer; 2024 Jul 24; 15(7):2045-2065. PubMed ID: 38434979
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.